ADVERTISEMENT
A Theranos sign outside the company's headquarters
Theranos Founder Elizabeth Holmes Convicted of Fraud
After a week of deliberation, a jury returned a guilty verdict on four charges related to wire fraud, each of which carries a maximum sentence of up to 20 years in prison.
Theranos Founder Elizabeth Holmes Convicted of Fraud
Theranos Founder Elizabeth Holmes Convicted of Fraud

After a week of deliberation, a jury returned a guilty verdict on four charges related to wire fraud, each of which carries a maximum sentence of up to 20 years in prison.

After a week of deliberation, a jury returned a guilty verdict on four charges related to wire fraud, each of which carries a maximum sentence of up to 20 years in prison.

business
UK Government to Boost R&D Spending
Catherine Offord | Mar 13, 2020 | 2 min read
The 2020 budget includes a 15 percent increase in public funding for research and development next year, but some scientists want more details on where the money will go.
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
Catherine Offord | Oct 14, 2019 | 2 min read
The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.
The Rise of Cannabis Extraction Labs
Chemyx Inc. | 5 min read
Scientists in cannabis extraction laboratories are bravely pioneering a new field of agro-chemical engineering.
computing a cure
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019 | 8 min read
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Former Taiwanese National Academy Head Cleared of Corruption
Ashley Yeager | Jan 3, 2019 | 1 min read
Wong Chi-huey, who was the president of Academia Sinica until 2016, was found not guilty of taking bribes from a pharmaceutical company.
DNA strands on a blue background
“Co-op” Lets Users Barter DNA and Health Information for Shares
Shawna Williams | Dec 7, 2018 | 2 min read
LunaDNA receives Securities and Exchange Commission approval to treat the data as currency.
a DNA strand
First Blockchain-based Genomic Data Marketplace Launches
Shawna Williams | Nov 5, 2018 | 2 min read
EncrypGen will enable individuals to sell their deidentified data for research.
Call to Stop Using the Term “Mesenchymal Stem Cell”
Abby Olena, PhD | Sep 26, 2018 | 4 min read
Critics say the misleading term actually refers to a heterogeneous population of cells, including possible tissue-specific progenitor cells and nonstem cells all lumped together.
Opinion: A Modest Proposal to Address NIH Insanity
Henry J. Rozycki | Aug 22, 2018 | 4 min read
Silicon Valley’s early-stage funding model could address a dearth of opportunities for young investigators just launching new projects.
Researchers React to Microsoft’s Acquisition of GitHub
Anna Azvolinsky | Jun 7, 2018 | 4 min read
Computational biologists are optimistic that the purchase of the world’s largest hub for open-source computer code will not affect the way they use GitHub for science.
MyHeritage Account Data Compromised in “Cybersecurity Incident”
Catherine Offord | Jun 6, 2018 | 2 min read
A security researcher found the email addresses and encrypted passwords of more than 92 million users of the genealogy site on a private server outside the company.
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018 | 3 min read
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018 | 2 min read
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
SEC Charges Theranos With Fraud
Jim Daley | Mar 14, 2018 | 2 min read
The company raised more than $700 million based on false claims to investors, according to the complaint.
Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals
Jim Daley | Jan 31, 2018 | 2 min read
Biotech stocks fell in response to the news. 
Should Healthy People Have Their Exomes Sequenced?
Ruth Williams | Mar 24, 2017 | 4 min read
With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  
Johnson & Johnson to Acquire Swiss Biotech Firm for $30 Billion
Joshua A. Krisch | Jan 26, 2017 | 1 min read
With its purchase of Actelion, Johnson & Johnson’s acquires experimental treatments for pulmonary arterial hypertension and several rare diseases.
That Other CRISPR Patent Dispute
Kerry Grens | Aug 31, 2016 | 5 min read
The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.
Former Affymetrix Employees Fail to Stop Thermo Fisher Takeover
Bob Grant | Mar 22, 2016 | 2 min read
Their $1.5 billion bid, which topped Thermo Fisher Scientific’s $1.3 billion offer for the genetic analysis company, was rejected.
ADVERTISEMENT